Contrarily, there was a consistent recovery achieved with the BPC 157 therapy, given at once, soon after injury (i.e., at 10 min post-injury), or much later (i.e., therapy at fourth post-injury day) [28,29]
That closes out the two-day vote with 6 of 7 peptides backed including yesterday's BPC-157, KPV, TB-500, and MOTS-c
Wegovy Tablet (NEW): Once-daily oral semaglutide 25 mg Average weight loss: 16.6% ~1/3 of patients achieved 20%+ weight loss Approved specifically for weight management Reduces cardiovascular event risk Rybelus (Available in Canada): Once-daily oral semaglutide 14 mg max Average weight loss: ~4% Originally approved for Type 2 Diabetes Prescribed off-label for weight loss The Verdict: Wegovy tablet is significantly more effective for weight loss - achieving results comparable to weekly Wegovy injections while Rybelus falls short at lower doses
Sources Bes, F., Jobert, M., Schulz, H., & Saletu, B
Additionally, Ipamorelin appeared to potentially increase the levels of serum leptin, a hormone believed to be involved in regulating energy balance and appetite